PCSK9 and chronic obstructive pulmonary disease: In a myocardial ischemia–reperfusion (I/R) model in Wistar rats, a PCSK9 inhibitor administered before ischemia exerted a cardioprotection, as demonstrated by the attenuation of infarct size and cardiac arrhythmia during cardiac I/R injury.